Unclaimed Scholar Profile
Are you Petrus J. de Vries? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at University of Cape TownASIDASID-6616-9603-0214 orcid.org/0000-0002-8915-1571
Petrus J. de Vries
University of Cape Town•South Africa
Faculty researcher at University of Cape Town (ZA), specializing in Social Sciences & Humanities. [Discipline: Social Sciences & Humanities] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#Tuberous Sclerosis Complex Research#Autism Spectrum Disorder Research#Family and Disability Support Research#Genetic and rare skin diseases.
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 13,496 | 6,478 |
| h-index | 57 | 43 |
| i10-index | 136 | 95 |
Annual Citation Growth
Verified Citations / Year0
2020648
2021+40%907
2022+29%1.2k
2023+33%1.6k
2024-8%1.4k
2025-45%777
2026Scholarship Distribution & Proportions197 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (11,067) • 18% Global Research Impact (2,429)
197 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (197)
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Published in The Lancet•2013
DOI: 10.1016/s0140-6736(12)61767-x Verified Peer-Reviewed
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Published in The Lancet•2012
DOI: 10.1016/s0140-6736(12)61134-9 Verified Peer-Reviewed
Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations
Published in Pediatric Neurology•2021
DOI: 10.1016/j.pediatrneurol.2021.07.011 Verified Peer-Reviewed
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study
Published in The Lancet•2016
DOI: 10.1016/s0140-6736(16)31419-2 Verified Peer-Reviewed
Developmental disabilities among children younger than 5 years in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Published in The Lancet Global Health•2018
DOI: 10.1016/s2214-109x(18)30309-7 Verified Peer-Reviewed
Showing 1 – 5 of 197 publications
1 / 40